A Martinetti - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Martinetti

Showing results (11-20 of 51) with videos related to

Pageof 6

Sort By:

European Journal of Nuclear Medicine|February 21, 1998

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?E Bombardieri, A Martinetti, R Miceli, et al.

The International Journal of Biological Markers|June 15, 1999

Hormonal regulation of MUC1 expressionE Seregni, C Botti, E Bajetta, et al.

Anticancer Research|May 5, 1999

The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporationS N Molteni, E Seregni, C Botti, et al.

Breast Cancer Research and Treatment|January 1, 1993

Urinary testosterone as a marker of risk of recurrence in operable breast cancerP Ballerini, S Oriana, P Duca, et al.

Anticancer Research|July 25, 1998

Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2AA Martinetti, E Seregni, F Belli, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 23, 2004

Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomasL Ferrari, E Seregni, G Aliberti, et al.

Oncology Reports|May 10, 2007

Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?A Martinetti, C Ripamonti, R Miceli, et al.

The International Journal of Biological Markers|July 1, 1997

Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extractionA Martinetti, E Seregni, E Bajetta, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsE Bajetta, N Zilembo, E Bichisao, et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997

Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestaneA Martinetti, E Bajetta, E Seregni, et al.

Pageof 6

Search research articles

Showing results (11-20 of 51) with videos related to